Brie Carter

Ethereum climbed 8.46 percent over the past 24 hours to reach $1,805.94, outperforming the broader cryptocurrency market, which advanced 7.69 percent during the same period.

Clinical-stage biotech company Clearmind Medicine (NASDAQ:CMND) has successfully completed the dosing of all 24 healthy participants in Part A of its FDA-regulated Phase I/II trial evaluating its proprietary compound, CMND-100, for the treatment of Alcohol Use Disorder.

Nebius (NASDAQ:NBIS) completed its corporate acquisition of model optimization developer Eigen AI on June 10, 2026.

Parsons (NYSE:PSN) secured design and construction oversight contracts for the estimated $1.1–$1.4 billion John A. Blatnik Bridge replacement project.

Waterdrop (NYSE:WDH) recorded net operating revenue of RMB1,242.2 million for the first quarter, representing a 64.8% year-over-year increase.

Uxin (NASDAQ:UXIN) reported total revenues of RMB1,073.7 million for the quarter ended March 31, 2026.

Federal Reserve Chair Kevin Warsh will lead his first policy meeting on June 17, with crypto investors closely watching whether policymakers maintain their current outlook or signal a more restrictive path for interest rates.

SpaceX surged more than 16% on its second day of trading, lifting the company's market value to approximately US$2.43 trillion.

Racura Oncology (ASX:RAC) has raised $34.3 million to fully fund three upcoming clinical trials.

XRP (CRYPTO:XRP) could attract a spot exchange-traded fund application from BlackRock, according to Digital Ascension Group Chairman Jake Claver, who linked the possibility to growing institutional interest in the XRP Ledger.